Robust clinical evidence on spinal cord stimulation (SCS)

We are committed to advancing SCS through high-quality robust clinical research on SCS indications using multiple stimulation waveforms, including low-dose, high-dose, tonic, and Differential Target Multiplexed™ spinal cord stimulation (DTM™ SCS).

 

Lower Limb

86%

of patients with diabetic peripheral neuropathy pain in the lower limbs reported treatment success after receiving SCS therapy for one year.†,1

Upper limb pain

100%

of subjects with upper-limb were satisfied or very satisfied with DTM™ SCS at 12 months.2

Back pain

2 RCTs

Medtronic conducted 2 randomized control trials (RCTs) that evaluated DTM™ SCS versus conventional stimulation.3,4

Evidence supporting SCS

Access recent, robust pre-clinical and clinical research.

Education materials

Explore courses, videos, and educational opportunities for pain physicians.

Connect with a representative

Sign up and a sales representative will be in touch.